Industry Research Reports
Home > Reports > Pharma & Healthcare > Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 100 Pages
Report ld: 3480151
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Prothrombin Complex Market Size(US$)
CAGR 2025-2031
11.8%
Market Size,2031
USD 4,251
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,177 million
Market Forecast in 2031(Value)
US$ 4,251 million
CAGR
11.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Prothrombin Complex by region & country, by Type, and by Application.
The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
MARKET SEGMENTATION
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
Segment by Application
- Hemophilia B
- Vitamin K Deficiency
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Prothrombin Complex in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Human Prothrombin Complex Product Introduction
1.2 Global Human Prothrombin Complex Market Size Forecast
1.2.1 Global Human Prothrombin Complex Sales Value (2020-2031)
1.2.2 Global Human Prothrombin Complex Sales Volume (2020-2031)
1.2.3 Global Human Prothrombin Complex Sales Price (2020-2031)
1.3 Human Prothrombin Complex Market Trends & Drivers
1.3.1 Human Prothrombin Complex Industry Trends
1.3.2 Human Prothrombin Complex Market Drivers & Opportunity
1.3.3 Human Prothrombin Complex Market Challenges
1.3.4 Human Prothrombin Complex Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Prothrombin Complex Players Revenue Ranking (2024)
2.2 Global Human Prothrombin Complex Revenue by Company (2020-2025)
2.3 Global Human Prothrombin Complex Players Sales Volume Ranking (2024)
2.4 Global Human Prothrombin Complex Sales Volume by Company Players (2020-2025)
2.5 Global Human Prothrombin Complex Average Price by Company (2020-2025)
2.6 Key Manufacturers Human Prothrombin Complex Manufacturing Base and Headquarters
2.7 Key Manufacturers Human Prothrombin Complex Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Prothrombin Complex
2.9 Human Prothrombin Complex Market Competitive Analysis
2.9.1 Human Prothrombin Complex Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Prothrombin Complex Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 500 IU/Vial
3.1.2 600 IU/Vial
3.1.3 1000 IU/Vial
3.1.4 Others
3.2 Global Human Prothrombin Complex Sales Value by Type
3.2.1 Global Human Prothrombin Complex Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Human Prothrombin Complex Sales Value, by Type (2020-2031)
3.2.3 Global Human Prothrombin Complex Sales Value, by Type (%) (2020-2031)
3.3 Global Human Prothrombin Complex Sales Volume by Type
3.3.1 Global Human Prothrombin Complex Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Human Prothrombin Complex Sales Volume, by Type (2020-2031)
3.3.3 Global Human Prothrombin Complex Sales Volume, by Type (%) (2020-2031)
3.4 Global Human Prothrombin Complex Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hemophilia B
4.1.2 Vitamin K Deficiency
4.1.3 Others
4.2 Global Human Prothrombin Complex Sales Value by Application
4.2.1 Global Human Prothrombin Complex Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Human Prothrombin Complex Sales Value, by Application (2020-2031)
4.2.3 Global Human Prothrombin Complex Sales Value, by Application (%) (2020-2031)
4.3 Global Human Prothrombin Complex Sales Volume by Application
4.3.1 Global Human Prothrombin Complex Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Human Prothrombin Complex Sales Volume, by Application (2020-2031)
4.3.3 Global Human Prothrombin Complex Sales Volume, by Application (%) (2020-2031)
4.4 Global Human Prothrombin Complex Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Human Prothrombin Complex Sales Value by Region
5.1.1 Global Human Prothrombin Complex Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Human Prothrombin Complex Sales Value by Region (2020-2025)
5.1.3 Global Human Prothrombin Complex Sales Value by Region (2026-2031)
5.1.4 Global Human Prothrombin Complex Sales Value by Region (%), (2020-2031)
5.2 Global Human Prothrombin Complex Sales Volume by Region
5.2.1 Global Human Prothrombin Complex Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Human Prothrombin Complex Sales Volume by Region (2020-2025)
5.2.3 Global Human Prothrombin Complex Sales Volume by Region (2026-2031)
5.2.4 Global Human Prothrombin Complex Sales Volume by Region (%), (2020-2031)
5.3 Global Human Prothrombin Complex Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Human Prothrombin Complex Sales Value, 2020-2031
5.4.2 North America Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Human Prothrombin Complex Sales Value, 2020-2031
5.5.2 Europe Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Human Prothrombin Complex Sales Value, 2020-2031
5.6.2 Asia Pacific Human Prothrombin Complex Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Human Prothrombin Complex Sales Value, 2020-2031
5.7.2 South America Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Prothrombin Complex Sales Value, 2020-2031
5.8.2 Middle East & Africa Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Prothrombin Complex Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Human Prothrombin Complex Sales Value
6.2.1 Key Countries/Regions Human Prothrombin Complex Sales Value, 2020-2031
6.2.2 Key Countries/Regions Human Prothrombin Complex Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Human Prothrombin Complex Sales Value, 2020-2031
6.3.2 United States Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Human Prothrombin Complex Sales Value, 2020-2031
6.4.2 Europe Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Human Prothrombin Complex Sales Value, 2020-2031
6.5.2 China Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.5.3 China Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Human Prothrombin Complex Sales Value, 2020-2031
6.6.2 Japan Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Human Prothrombin Complex Sales Value, 2020-2031
6.7.2 South Korea Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Human Prothrombin Complex Sales Value, 2020-2031
6.8.2 Southeast Asia Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Human Prothrombin Complex Sales Value, 2020-2031
6.9.2 India Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.9.3 India Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Takeda Human Prothrombin Complex Product Offerings
7.1.5 Takeda Recent Development
7.2 CSL
7.2.1 CSL Company Information
7.2.2 CSL Introduction and Business Overview
7.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 CSL Human Prothrombin Complex Product Offerings
7.2.5 CSL Recent Development
7.3 Grifols
7.3.1 Grifols Company Information
7.3.2 Grifols Introduction and Business Overview
7.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Grifols Human Prothrombin Complex Product Offerings
7.3.5 Grifols Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Octapharma Human Prothrombin Complex Product Offerings
7.4.5 Octapharma Recent Development
7.5 Hualan Biological
7.5.1 Hualan Biological Company Information
7.5.2 Hualan Biological Introduction and Business Overview
7.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Hualan Biological Human Prothrombin Complex Product Offerings
7.5.5 Hualan Biological Recent Development
7.6 Meheco Xinxing Pharma
7.6.1 Meheco Xinxing Pharma Company Information
7.6.2 Meheco Xinxing Pharma Introduction and Business Overview
7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Offerings
7.6.5 Meheco Xinxing Pharma Recent Development
8 Industry Chain Analysis
8.1 Human Prothrombin Complex Industrial Chain
8.2 Human Prothrombin Complex Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Prothrombin Complex Sales Model
8.5.2 Sales Channel
8.5.3 Human Prothrombin Complex Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Human Prothrombin Complex Market Trends
Table 2. Human Prothrombin Complex Market Drivers & Opportunity
Table 3. Human Prothrombin Complex Market Challenges
Table 4. Human Prothrombin Complex Market Restraints
Table 5. Global Human Prothrombin Complex Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
Table 7. Global Human Prothrombin Complex Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Human Prothrombin Complex Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Human Prothrombin Complex Price by Company (2020-2025) & (M USD/Unit)
Table 10. Key Manufacturers Human Prothrombin Complex Manufacturing Base and Headquarters
Table 11. Key Manufacturers Human Prothrombin Complex Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Human Prothrombin Complex
Table 13. Global Human Prothrombin Complex Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Prothrombin Complex Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Human Prothrombin Complex Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Human Prothrombin Complex Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Human Prothrombin Complex Sales Market Share in Value by Type (2020-2025)
Table 20. Global Human Prothrombin Complex Sales Market Share in Value by Type (2026-2031)
Table 21. Global Human Prothrombin Complex Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Human Prothrombin Complex Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Human Prothrombin Complex Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Human Prothrombin Complex Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Human Prothrombin Complex Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Human Prothrombin Complex Price by Type (2020-2025) & (M USD/Unit)
Table 27. Global Human Prothrombin Complex Price by Type (2026-2031) & (M USD/Unit)
Table 28. Global Human Prothrombin Complex Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Human Prothrombin Complex Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Human Prothrombin Complex Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Human Prothrombin Complex Sales Market Share in Value by Application (2020-2025)
Table 32. Global Human Prothrombin Complex Sales Market Share in Value by Application (2026-2031)
Table 33. Global Human Prothrombin Complex Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Human Prothrombin Complex Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Human Prothrombin Complex Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Human Prothrombin Complex Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Human Prothrombin Complex Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Human Prothrombin Complex Price by Application (2020-2025) & (M USD/Unit)
Table 39. Global Human Prothrombin Complex Price by Application (2026-2031) & (M USD/Unit)
Table 40. Global Human Prothrombin Complex Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Human Prothrombin Complex Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Human Prothrombin Complex Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Human Prothrombin Complex Sales Value by Region (2020-2025) & (%)
Table 44. Global Human Prothrombin Complex Sales Value by Region (2026-2031) & (%)
Table 45. Global Human Prothrombin Complex Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Human Prothrombin Complex Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Human Prothrombin Complex Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Human Prothrombin Complex Sales Volume by Region (2020-2025) & (%)
Table 49. Global Human Prothrombin Complex Sales Volume by Region (2026-2031) & (%)
Table 50. Global Human Prothrombin Complex Average Price by Region (2020-2025) & (M USD/Unit)
Table 51. Global Human Prothrombin Complex Average Price by Region (2026-2031) & (M USD/Unit)
Table 52. Key Countries/Regions Human Prothrombin Complex Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Human Prothrombin Complex Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Human Prothrombin Complex Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Human Prothrombin Complex Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Human Prothrombin Complex Sales Volume, (2026-2031) & (K Units)
Table 57. Takeda Company Information
Table 58. Takeda Introduction and Business Overview
Table 59. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 60. Takeda Human Prothrombin Complex Product Offerings
Table 61. Takeda Recent Development
Table 62. CSL Company Information
Table 63. CSL Introduction and Business Overview
Table 64. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 65. CSL Human Prothrombin Complex Product Offerings
Table 66. CSL Recent Development
Table 67. Grifols Company Information
Table 68. Grifols Introduction and Business Overview
Table 69. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 70. Grifols Human Prothrombin Complex Product Offerings
Table 71. Grifols Recent Development
Table 72. Octapharma Company Information
Table 73. Octapharma Introduction and Business Overview
Table 74. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 75. Octapharma Human Prothrombin Complex Product Offerings
Table 76. Octapharma Recent Development
Table 77. Hualan Biological Company Information
Table 78. Hualan Biological Introduction and Business Overview
Table 79. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 80. Hualan Biological Human Prothrombin Complex Product Offerings
Table 81. Hualan Biological Recent Development
Table 82. Meheco Xinxing Pharma Company Information
Table 83. Meheco Xinxing Pharma Introduction and Business Overview
Table 84. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 85. Meheco Xinxing Pharma Human Prothrombin Complex Product Offerings
Table 86. Meheco Xinxing Pharma Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Human Prothrombin Complex Downstream Customers
Table 90. Human Prothrombin Complex Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Prothrombin Complex Product Picture
Figure 2. Global Human Prothrombin Complex Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Human Prothrombin Complex Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Human Prothrombin Complex Sales Volume (2020-2031) & (K Units)
Figure 5. Global Human Prothrombin Complex Sales Price (2020-2031) & (M USD/Unit)
Figure 6. Human Prothrombin Complex Report Years Considered
Figure 7. Global Human Prothrombin Complex Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Human Prothrombin Complex Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Prothrombin Complex Revenue in 2024
Figure 10. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. 500 IU/Vial Picture
Figure 12. 600 IU/Vial Picture
Figure 13. 1000 IU/Vial Picture
Figure 14. Others Picture
Figure 15. Global Human Prothrombin Complex Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Human Prothrombin Complex Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Human Prothrombin Complex Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Human Prothrombin Complex Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Human Prothrombin Complex Price by Type (2020-2031) & (M USD/Unit)
Figure 20. Product Picture of Hemophilia B
Figure 21. Product Picture of Vitamin K Deficiency
Figure 22. Product Picture of Others
Figure 23. Global Human Prothrombin Complex Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Human Prothrombin Complex Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Human Prothrombin Complex Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 26. Global Human Prothrombin Complex Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Human Prothrombin Complex Price by Application (2020-2031) & (M USD/Unit)
Figure 28. North America Human Prothrombin Complex Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Human Prothrombin Complex Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Human Prothrombin Complex Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Human Prothrombin Complex Sales Volume (%), (2020-2031)
Figure 40. United States Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
Figure 46. China Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
Figure 48. China Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
Figure 58. India Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
Figure 60. India Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
Figure 61. Human Prothrombin Complex Industrial Chain
Figure 62. Human Prothrombin Complex Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Human Prothrombin Complex market?
The top companies in the global Human Prothrombin Complex market are Takeda、CSL、Grifols.
What was the global market size of Human Prothrombin Complex in 2025?
What was the global market size of Human Prothrombin Complex in 2031?
What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2025 to 2031?
Which region is expected to have the highest market share?
Related Reports
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
USD 4900.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now